Adam Elsesser, the CEO and President of $PEN, sold 600 shares of the company on 03-19-2025 for an estimated $167,334. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.1% of their shares of this class of stock. Following this trade, they now own 27,752 shares of this class of $PEN stock.
$PEN Insider Trading Activity
$PEN insiders have traded $PEN stock on the open market 92 times in the past 6 months. Of those trades, 0 have been purchases and 92 have been sales.
Here’s a breakdown of recent trading of $PEN stock by insiders over the last 6 months:
- ADAM ELSESSER (CEO and President) has made 0 purchases and 34 sales selling 138,200 shares for an estimated $35,291,681.
- ARANI BOSE has made 0 purchases and 11 sales selling 12,000 shares for an estimated $3,448,992.
- LAMBERT SHIU (Chief Accounting Officer) has made 0 purchases and 10 sales selling 10,241 shares for an estimated $2,820,634.
- JOHANNA ROBERTS (EVP, Gen. Counsel & Secretary) has made 0 purchases and 27 sales selling 2,400 shares for an estimated $577,453.
- MAGGIE YUEN (Chief Financial Officer) has made 0 purchases and 5 sales selling 2,000 shares for an estimated $571,994.
- DON W. KASSING has made 0 purchases and 2 sales selling 340 shares for an estimated $73,570.
- HARPREET GREWAL has made 0 purchases and 2 sales selling 333 shares for an estimated $71,971.
- BRIDGET O'ROURKE sold 50 shares for an estimated $14,274
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PEN Hedge Fund Activity
We have seen 178 institutional investors add shares of $PEN stock to their portfolio, and 203 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 719,571 shares (-36.2%) from their portfolio in Q4 2024, for an estimated $170,883,721
- EAGLE ASSET MANAGEMENT INC removed 327,932 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $63,720,466
- CITADEL ADVISORS LLC added 322,265 shares (+78.2%) to their portfolio in Q4 2024, for an estimated $76,531,492
- JPMORGAN CHASE & CO removed 253,114 shares (-65.9%) from their portfolio in Q4 2024, for an estimated $60,109,512
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 227,506 shares (+47.4%) to their portfolio in Q4 2024, for an estimated $54,028,124
- QUBE RESEARCH & TECHNOLOGIES LTD removed 190,378 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $36,992,349
- BRAIDWELL LP removed 177,600 shares (-49.1%) from their portfolio in Q4 2024, for an estimated $42,176,448
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PEN Analyst Ratings
Wall Street analysts have issued reports on $PEN in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 12/11/2024
- RBC Capital issued a "Outperform" rating on 10/31/2024
- Deutsche Bank issued a "Buy" rating on 10/31/2024
- Piper Sandler issued a "Overweight" rating on 10/18/2024
- Canaccord Genuity issued a "Buy" rating on 10/16/2024
- BTIG issued a "Buy" rating on 10/14/2024
To track analyst ratings and price targets for $PEN, check out Quiver Quantitative's $PEN forecast page.
$PEN Price Targets
Multiple analysts have issued price targets for $PEN recently. We have seen 7 analysts offer price targets for $PEN in the last 6 months, with a median target of $235.0.
Here are some recent targets:
- Larry Biegelsen from Wells Fargo set a target price of $275.0 on 12/11/2024
- Matt O'Brien from Piper Sandler set a target price of $235.0 on 10/31/2024
- Pito Chickering from Deutsche Bank set a target price of $241.0 on 10/31/2024
- Jason Mills from Canaccord Genuity set a target price of $235.0 on 10/16/2024
- David Rescott from Robert W. Baird set a target price of $244.0 on 10/15/2024
- Richard Newitter from Truist Financial set a target price of $235.0 on 10/14/2024
- Shagun Singh from RBC Capital set a target price of $222.0 on 10/08/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.